Selling or distributing an unapproved drug is considered a federal violation
EClinicalMedicine 3(72):102624 Jensen SBK, Srensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR et al (2024) Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial
Contributed by Akshi Seem, Associate Partner Read More: #PatentLaw #DelhiHighCourt #AccessToMedicine #Pharma #IntellectualProperty #MaheshwariAndCo To view or add a comment, sign in CANADA APPROVES NEW PATENT The Canadian Intellectual Property Office / Office de la proprit intellectuelle du Canada (CIPO) has granted Palisade Bio a patent for its PALI-2108 therapy, a gut-targeted PDE4 B/D inhibitor being developed for ulcerative colitis (UC) and fibrostenotic Crohns disease (FSCD)
Offer End In: 100.00Add to cart Liposomal R-Alpha-Lipoic Acid R-ALA 30 capsules Liposomal R-Alpha-Lipoic Acid R-ALA 30 capsules Hurry Up
Scientific Reports , 14 (1), 20240